To assess the absolute and comparative benefit and tolerability of pharmacological therapies for the treatment of central neuropathic pain syndromes in people with MS.
This is a protocol.
To assess the absolute and comparative benefit and tolerability of pharmacological therapies for the treatment of central neuropathic pain syndromes in people with MS.
This is a protocol.